These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 16201181)
41. Epididymo-orchitis caused by intravesically instillated bacillus Calmette-Guérin: genetically proven using a multiplex polymerase chain reaction method. Harada H; Seki M; Shinojima H; Miura M; Hirano T; Togashi M Int J Urol; 2006 Feb; 13(2):183-5. PubMed ID: 16563148 [TBL] [Abstract][Full Text] [Related]
42. Role of a bacillus Calmette-Guérin fibronectin attachment protein in BCG-induced antitumor activity. Zhao W; Schorey JS; Bong-Mastek M; Ritchey J; Brown EJ; Ratliff TL Int J Cancer; 2000 Apr; 86(1):83-8. PubMed ID: 10728599 [TBL] [Abstract][Full Text] [Related]
43. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Han RF; Pan JG Urology; 2006 Jun; 67(6):1216-23. PubMed ID: 16765182 [TBL] [Abstract][Full Text] [Related]
44. Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C. Stoehr B; Mueller T; Granig T; Zangerl F; Steiner H BJU Int; 2008 Dec; 102(11):1556-9. PubMed ID: 18691179 [TBL] [Abstract][Full Text] [Related]
45. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder. Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737 [TBL] [Abstract][Full Text] [Related]
46. Bacillus Calmette-Guerin mechanism of action: the role of immunity, apoptosis, necrosis and autophagy. DiPaola RS; Lattime EC J Urol; 2007 Nov; 178(5):1840-1. PubMed ID: 17868741 [No Abstract] [Full Text] [Related]
47. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. Yutkin V; Pode D; Pikarsky E; Mandelboim O J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285 [TBL] [Abstract][Full Text] [Related]
48. [Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes]. Chen JH; Li Y; Yao Q; Ling R; Wang L; Li KZ; Wang Z; Chen T Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3039-42. PubMed ID: 16324402 [TBL] [Abstract][Full Text] [Related]
49. Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation. Hidoussi A; Slama A; Jaidane M; Zakhama W; Youssef A; Ben Sorba N; Mosbah AF Urology; 2007 Sep; 70(3):591.e9-10. PubMed ID: 17905131 [TBL] [Abstract][Full Text] [Related]
50. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy. Yusuke H; Yoshinori H; Kenichi M; Akio H Int J Urol; 2006 Oct; 13(10):1361-3. PubMed ID: 17010022 [TBL] [Abstract][Full Text] [Related]
51. Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer. Kaneko T; Fujita K; Homma Y Int J Urol; 2006 Mar; 13(3):294-5. PubMed ID: 16643629 [TBL] [Abstract][Full Text] [Related]
52. [Bladder contracture following intravesical BCG immunotherapy treated by hydrodistention: a case report]. Sawada A; Yagihashi Y; Kawase N; Fukuzawa S Hinyokika Kiyo; 2006 Jan; 52(1):59-61. PubMed ID: 16479993 [TBL] [Abstract][Full Text] [Related]
53. Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells. Lodillinsky C; Umerez MS; Jasnis MA; Casabé A; Sandes E; Eiján AM Int J Mol Med; 2006 Feb; 17(2):269-73. PubMed ID: 16391825 [TBL] [Abstract][Full Text] [Related]
55. Intravesical mycobacterial cell wall-DNA complex in the treatment of carcinoma in situ of the bladder after standard intravesical therapy has failed. Morales A; Phadke K; Steinhoff G J Urol; 2009 Mar; 181(3):1040-5. PubMed ID: 19150551 [TBL] [Abstract][Full Text] [Related]
56. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts. Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729 [TBL] [Abstract][Full Text] [Related]
57. Discontinuance of bacille Calmette-Guérin instillation therapy for nonmuscle-invasive bladder cancer has negative effect on tumor recurrence. Takeda T; Kikuchi E; Yuge K; Matsumoto K; Miyajima A; Nakagawa K; Oya M Urology; 2009 Jun; 73(6):1318-22. PubMed ID: 19232694 [TBL] [Abstract][Full Text] [Related]
58. Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer. Demkow T; Alter A; Wiechno P Urol Int; 2008; 80(1):74-9. PubMed ID: 18204238 [TBL] [Abstract][Full Text] [Related]
59. Efficacy of intramuscular BCG polysaccharide nucleotide on mild to moderate bronchial asthma accompanied with allergic rhinitis: a randomized, double blind, placebo-controlled study. Li J; Luo DF; Li SY; Sun BQ; Zhong NS Chin Med J (Engl); 2005 Oct; 118(19):1595-603. PubMed ID: 16232343 [TBL] [Abstract][Full Text] [Related]
60. DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin. Oliveira PA; Palmeira C; Colaço A; de la Cruz LF; Lopes C Anticancer Res; 2006; 26(4B):2995-3004. PubMed ID: 16886626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]